Asston Pharmaceuticals has submitted a compliance certificate for a quarter, received from its Registrar and Share Transfer Agent.

This certificate confirms the proper handling of share transfers and dematerialization requests.

This update assures investors of the company's adherence to share-related regulatory procedures, ensuring transparency and efficiency in managing its shareholder records.

It reflects sound operational practices in maintaining the company's share capital and fulfilling standard compliance obligations.